Amy Camuso

Tumor Development by Transgenic Expression of a Constitutively Active Insulin-Like Growth Factor I Receptor

Joan M. Carboni, Adrian V. Lee, Darryl L. Hadsell et al. · Cancer Research · 2005 · 203 citations · Full text

Receptor Antagonists, Cell Proliferation, Tumor Biology +16

Dasatinib (BMS-354825) Pharmacokinetics and Pharmacodynamic Biomarkers in Animal Models Predict Optimal Clinical Exposure

Feng Luo, Zheng Yang, Amy Camuso et al. · Clinical Cancer Research · 2006 · 149 citations

Correlation of pharmacokinetics with the antitumor activity of Cetuximab in nude mice bearing the GEO human colon carcinoma xenograft

Feng Luo, Zheng Yang, Huijing Dong et al. · Cancer Chemotherapy and Pharmacology · 2005 · 85 citations

Oncology, Antitumor Activity, Nude Mice +7

Cetuximab preclinical antitumor activity (monotherapy and combination based) is not predicted by relative total or activated epidermal growth factor receptor tumor expression levels

Robert A. Wild, Krista Fager, Christine Flefleh et al. · Molecular Cancer Therapeutics · 2006 · 62 citations

Tumor Biology, Widr Models, Medicine +14

Identification and validation of phospho-SRC, a novel and potential pharmacodynamic biomarker for dasatinib (SPRYCEL™), a multi-targeted kinase inhibitor

Feng Luo, Yu Chen Barrett, Zheng Yang et al. · Cancer Chemotherapy and Pharmacology · 2008 · 50 citations · Full text

Hematological Malignancy, Tumor Biology, Drug Targeting +14